LCM
AGN.PRA

Lakewood Capital Management’s Allergan plc AGN.PRA Stock Holding History

Lakewood Capital Management’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-90,150
Closed -$66.5M – 40
2017
Q3 		$66.5M Hold
90,150
– – 2.4% 16
2017
Q2 		$78.2M Sell
90,150
-7,450
-8% -$6.24M 3.08% 14
2017
Q1 		$82.8M Buy
97,600
+4,600
+5% +$3.81M 3.44% 12
2016
Q4 		$70.9M Buy
93,000
+60,200
+184% +$45.5M 3.21% 13
2016
Q3 		$26.9M Sell
32,800
-21,000
-39% -$18.2M 0.61% 30
2016
Q2 		$44.8M Buy
+53,800
New +$44.9M 2.17% 17

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Lakewood Capital Management's AGN.PRA Position: Q4 2017 in Review

Lakewood Capital Management sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 90,150 shares — an estimated $66.5M sold.

Lakewood Capital Management first reported a position in AGN.PRA in Q2 2016 and held it in 6 quarters. The position peaked at $82.8M in Q1 2017. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Lakewood Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Lakewood Capital Management sold 90,150 Allergan plc shares in Q4 2017, an estimated $66.5M.
  • Lakewood Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Lakewood Capital Management's Allergan plc position peaked at $82.8M in Q1 2017.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Lakewood Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.